CClinicalTrials.gg
CompletedNCT01956682Updated Apr 1, 2015

Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying

A Phase 4 interventional study of HA formula + starch + L. reuteri in Regurgitation, Gastric, sponsored by University of Bari. Completed at 1 site in Italy. Open to participants aged 5 Days to 5 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-01.

Sponsored by University of Bari · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
5 Days to 5 Months
Sex
All
01

Study summary

The primary objective of this trial is to show that an hypoallergenic infant starter formula containing starch and the probiotic L. reuteri decreases the severity of regurgitation/spitting-up in infants presenting regurgitation/spitting-up , and who have taken it for 4 weeks, in comparison with a standard infant starter formula.

Read the detailed description

The primary objective of this trial is to show that the test formula (HA formula + starch + L. reuteri) decreases the severity (frequency + volume) of regurgitation/spitting-up in infants and ultrasound gastric emptying time, compared to a classical infant starter formula.

02

Conditions studied

  • Regurgitation, Gastric
03

In context

Laryngopharyngeal Reflux

56 studies on the registry are indexed under Laryngopharyngeal Reflux; 9 are open to participants now.

This study's enrollment of 132 is above the median of 72 across 37 interventional studies indexed under Laryngopharyngeal Reflux.

Browse Laryngopharyngeal Reflux studies →

Lead sponsor

University of Bari is the lead sponsor of 75 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Days to 5 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Full term infant (37 weeks ≤ gestation ≤ 42 weeks)
  • Age of infant between 5 days and 5 months
  • NGA
  • Infant exclusively formula-fed at enrollment
  • Presenting regurgitation/spitting-up according to the parents' perception
  • Vandenplas score of at least 2 and maximum 5
  • Having obtained the subject's legal representative's written informed consent

Exclusion criteria

Exclusion Criteria:

  • Previous antireflux treatment
  • Previous consumption of AR infant formula or external thickener
  • Previous consumption of a formula with L. reuteri
  • Cow's milk allergy symptoms according to medical decision
  • Congenital illness or malformation that may affect growth
  • Significant pre-natal and/or post-natal disease
  • Newborn whose parents / caregivers cannot be expected to comply with study procedures
  • Newborn currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
132 participants (actual)

Study arms

  • Active comparator
    Infant formula

    HA formula + starch + L. reuteri

    Dietary Supplement: HA formula + starch + L. reuteri

  • Placebo comparator
    Standard Formula

    Standard Infant Formula

Interventions

  • Dietary supplementHA formula + starch + L. reuteri
06

What researchers measure

Primary outcomes

  1. Regurgitation

    The primary outcome is the difference in the proportions of improved subjects at four weeks of treatment between the treatment and control groups.

    Time frame: four weeks of treatment

Secondary outcomes

  1. Growth

    To assess whether the groups have comparable growth

    Time frame: Four weeks of treatment

  2. Regurgitation score

    To assess the severity of regurgitation/spitting-up To assess the frequency of regurgitation/spitting-up To assess the volume of regurgitation/spitting-up

    Time frame: Four weeks treatment

  3. Gastric empty rate

    To compare the ultrasound gastric empty rate

    Time frame: Four week treatment

  4. Digestive tolerance

    To assess the infants' digestive tolerance

    Time frame: Four weeks treatment

  5. Stool frequency

    To assess stool frequency

    Time frame: Four weeks treatment

  6. compliance

    To assess the subject's compliance to product consumption.

    Time frame: four weeks intervention

  7. Financial and non-financial burden

    To measure family financial and non-financial burden related with the regurgitation

    Time frame: Four week treatment

07

Study locations

1 site
  • Ospedale Pediatrico Giovanni XXIII
    Bari, BA 70100, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01956682
Lead sponsor
University of Bari
Responsible party
Flavia Indrio (M.D., University of Bari) — Principal investigator
First posted
Oct 8, 2013
Start date
Oct 2014
Primary completion
Mar 2015
Completion
Mar 2015
Last update
Apr 1, 2015

Study contacts

Flavia Indrio, MD
principal investigator · University of Bari

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion